Fresh from our latest episode on pharmacies and their social role, our esteemed colleague and serial guest of the show Megan returns to chat a bit more with us on the industry of medicine as a whole.\n\nWe scrutinize publishing standards, lobbying, patents, and controversies surrounding pricing in the big business of Big Pharma.\n\nQUOTE: "No society can understand itself without looking at its shadow side." - Gabor Mat\xe9, 'In the Realm of Hungry Ghosts: Close Encounters with Addition'\n\n#FrivolousGravitas Links: \nChannel: https://www.youtube.com/channel/UCb3cCrFqaHFBp2s7jgtJvFg \nFB: https://www.facebook.com/Frivolous-Gravitas-Podcast-109356198202987/ \nTwitter: https://twitter.com/FrivolousGravi1 \nRSS: https://krisdriver.com/feed/rssfeed.xml \n\nAs always, if you like this kind of content and want to see more, be sure to like, share and subscribe to help keep this channel going.\n\nUse RSS url to subscribe to Frivolous Gravitas using your favorite podcast player to catch up on past episodes and listen any time you want. No commercials, no sponsors, no ads, just straight talk on demand and on the go.\n\nOriginal Music by Dreamlife\n\nSOURCES / REFERENCES:\nresearchintegrityjournal.biomedcentral.com/articles/10.1186/s41073-019-0074-6\n"This study underscores the importance of timely and accurate publication and dissemination of trial results, in order to avoid the potential waste of resources and to ensure research integrity and patient safety. "\n\nwww.ncbi.nlm.nih.gov/pmc/articles/PMC5696751/\n"Dealing with the positive publication bias: Why you should really publish your negative results"\n\nwww.sciencedirect.com/science/article/abs/pii/S0140673616313575\n"Interpretation of the evidence for the efficacy and safety of statin therapy"\n\nwww.youtube.com/watch?v=RKmxL8VYy0M\n\nwww.samhsa.gov/data/sites/default/files/NSDUH-DSM5ImpactAdultMI-2016.pdf\n"IMPACT OF THE DSM-IV TO DSM-5 CHANGES ON THE NATIONAL SURVEY ON DRUG USE AND HEALTH "\n(-quoted page 134)\n\n\u201cRecently, we examined our current files to determine the incidence of narcotic addiction in 39,946 hospitalized medical patients who were monitored consecutively. Although there were 11, 882 patients who received at least one narcotic preparation, there were only four cases of reasonable well documented addiction in patients who had no history of addiction. The addiction was considered major in only one instance. The drugs implicated were meperidine in two patients, Percodan in one, and hydromorphone in one. We conclude that despite widespread use of narcotic drugs in hospitals, the development of addiction is rare in medical patients with no history of addiction.\u201d - Porter and Jick, 1980, \u201cAddiction Rare in Patients Treated with Narcotics\u201d New England Journal of Medicine